ABSTRACT
Germanium nanocrystals (Ge NCs) have potential to be used in several optoelectronic applications such as photodetectors and light-emitting diodes. Here, we report a solid-state route to synthesizing Ge NCs through thermal disproportionation of a germania (GeOX) glass, which was synthesized by hydrolyzing a GeCl2·dioxane complex. The GeOX glass synthesized in this manner was found to have residual Cl content. The process of nanocrystal nucleation and growth was monitored using powder X-ray diffraction, transmission electron microscopy, X-ray photoelectron spectroscopy and Raman spectroscopy. Compared to existing solid-state routes for synthesizing colloidal Ge NCs, this approach requires fewer steps and is amenable to scaling to large-scale reactions.
ABSTRACT
Bismuth-based halide perovskites have been proposed as a potential nontoxic alternative to lead halide perovskites; however, they have not realized suitable performance. Their poor performance has been attributed to substandard film morphologies and too wide of a band gap for many applications. Herein we used a two-step deposition procedure to convert BiI3 thin films into A3Bi2I9 (A = FA+, MA+, Cs+, or Rb+), which resulted in a substantial improvement in film morphology, a larger band gap, and greater compositional tunability compared toresults when using aconventional single-step deposition technique. Additionally, we attempted to reduce the undesirably wide band gap in Rb3Bi2I9 thin films by inducing chemical pressures through cation-size mismatch, with an underlying hypothesis that cation-size mismatch could induce compressive strain within the 2D Rb3Bi2I9 lattice. However, we found that all A xRb3- xBi2I9 compositions with x > 0 adopted the 0D structure, and no changes to the band gap were observed with alloy. These results imply that the band gap of A xRb3- xBi2I9 is insensitive to A-site alloying.
ABSTRACT
An urgent need to deliver therapeutics across the blood-brain barrier (BBB) underlies a paucity of effective therapies currently available for treatment of degenerative, infectious, traumatic, chemical, and metabolic disorders of the nervous system. With an eye toward achieving this goal, an in vitro BBB model was employed to simulate biodegradable polyanhydride nanoparticle-based drug delivery to the brain. Using a combination of confocal microscopy, flow cytometry, and high performance liquid chromatography, we examined the potential of polyanhydride nanoparticles containing the anti-oxidant, mito-apocynin, to be internalized and then transferred from monocytes to human brain microvascular endothelial cells. The efficacy of this nanoparticle-based delivery platform was demonstrated by neuronal protection against oxidative stress. Taken together, this polyanhydride nanoparticle-based delivery system holds promise for enhancing neuroprotection by facilitating drug transport across the BBB. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2881-2890, 2018.
